In December 2004, the Medicines Control Council(MCC) rejected an application by the university for the approval of a clinical trial which would involve the administration of Nevirapine as a prophylactic to babies in order to prevent the transmission of the HIV virus from HIV infected mothers to their infants during breast feeding.
AIDS deaths in South Africa could be cut dramatically, reducing the epidemic to the level of a chronic illness and saving billions of dollars if the country adopted treatment practices followed in the United States, a study has found.
Over 8 000 health practitioners have been struck off the roll after failing to pay their annual fees, the Health Professionals' Council of South Africa (HPSCA) said on Thursday.
Many people are calling urgently for laws and policies to curtail or prevent HIV/AIDS stigma. This is a call for changes in structures. It is also a useless exercise, until such time as we examine the roots of stigma, and understand its very nature. Then we can build structures to support the understandings and mechanisms that alleviate stigma.
Eighty-year-old Jan de Groot, who learnt he was HIV-positive at the age of 67, writes about living and coping with AIDS.
The Gauteng Department of Health is hosting a two-day Nursing Education Conference to discuss major challenges facing the nursing profession in the province.
An illegal medicines industry is rocketing out of control as unregistered products - many claiming to cure diseases such as cancer, TB and AIDS - are sold across the counter or on the streets.
Although the operating performance of medical schemes took a knock last year, a survey by Global Credit Ratings has found that schemes are financially robust.
The Department of Health takes note of the Constitutional Court judgement of 17 August 2006 in the matter between Doctors for Life v/s the National Assembly, NCOP and the Department of Health.
REGISTRAR OF MEDICAL SCHEMES CLARIFIES IMPLEMENTATION OF PRESCRIBED MINIMUM BENEFITS AND WAITING PERIODS
Responding to inconsistencies in the implementation of prescribed minimum benefits (PMBs) and the application of waiting periods by medical schemes, The Registrar of Medical Schemes, T. Patrick Masobe, has issued a circular outlining the manner in which these issues should be dealt with by medical schemes. Masobe is concerned that many schemes have not been providing members with the benefits they are entitled to in terms of the requirements of the minimum benefits legislation. Another concern which has prompted this action relates to the manner in which medical schemes impose waiting period on members, especially those who would normally be entitled to receive services regarded as prescribed minimum benefits.